Kommer en avtale? Snart må sluttresultat pesenteres.

Feb 24, 2021
Targovax’s Mesothelioma Candidate Shines in Latest Survival Data
"a median overall survival time of at least 20.5 months"
https://mesowatch.com/targovaxs-mesothelioma-candidate-shines-in-latest-survival-data/

Noen måneder senere:
ONCOS-102 Vaccine Showing Impressive Results for Mesothelioma
"an overall survival rate of between 21.9 and 25 months"
https://www.asbestos.com/news/2021/06/17/oncos-102-vaccine-mesothelioma/